These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8540531)

  • 1. Acute exacerbation of antiliver cytosol antibody-positive autoimmune chronic hepatitis by alpha-interferon.
    Gschwantler M; Schrutka-Kölbl C; Weiss W
    Am J Gastroenterol; 1995 Dec; 90(12):2239-40. PubMed ID: 8540531
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autoantibody against interleukin-1 alpha is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment.
    Itoh Y; Okanoue T; Sakamoto S; Nishioji K; Kashima K; Ohmoto Y
    Am J Gastroenterol; 1995 May; 90(5):777-82. PubMed ID: 7733087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha associated arthritis.
    Chung A; Older SA
    J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C virus, interferon alpha, and dysthyroidism].
    Marcellin P; Pouteau M; Messian O; Bok B; Erlinger S; Benhamou JP
    Gastroenterol Clin Biol; 1993; 17(12):887-91. PubMed ID: 8125219
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Report of a case: hepatic failure after treatment with interferon].
    Lindahl K; Weiland O; Schvarcz R
    Lakartidningen; 1993 Sep; 90(37):3075-6. PubMed ID: 8264269
    [No Abstract]   [Full Text] [Related]  

  • 10. Exacerbation of liver disease during interferon-alpha therapy for chronic hepatitis C.
    van der Watt M; Lemmer E; Robson SC
    S Afr Med J; 1994 Aug; 84(8 Pt 1):509. PubMed ID: 7825090
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune thrombocytopenia after alpha-interferon therapy in a patient with chronic hepatitis C.
    López Morante AJ; Sáez-Royuela F; Casanova Valero F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Am J Gastroenterol; 1992 Jun; 87(6):809-10. PubMed ID: 1590332
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
    Lunel F; Cacoub P
    Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune chronic hepatitis exacerbated by alpha-interferon.
    Papo T; Marcellin P; Bernuau J; Durand F; Poynard T; Benhamou JP
    Ann Intern Med; 1992 Jan; 116(1):51-3. PubMed ID: 1727095
    [No Abstract]   [Full Text] [Related]  

  • 15. Exacerbation of chronic hepatitis D during interferon alpha administration.
    Crosignani A; Invernizzi P; Ferrari R; Manzin A; Bruno S; Zuin M; Bianchi FB; Podda M
    Ital J Gastroenterol Hepatol; 1999; 31(1):66-9. PubMed ID: 10091106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune hepatitis and/or hepatitis C].
    Simonović J; Dokić Lj; Svirtlih N; Djordjević M; Bozić N; Poluga J
    Srp Arh Celok Lek; 1999; 127(3-4):109-13. PubMed ID: 10500434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon and ribavirin for hepatitis C.
    TreatmentUpdate; 2000 May; 12(3):6-7. PubMed ID: 12125615
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
    Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
    Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
    Cianciara J; Laskus T
    Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.